Biocryst Pharmaceuticals Inc (BCRX)
Sector • Healthcare Industry • Biotechnology & Pharmaceuticals |
Industry • Biotechnology & Pharmaceuticals |
Sector • Healthcare |
News
Biocryst Pharmaceutical*s Inducement Grants and Impact on Company Shares
BioCryst Pharmaceuticals Expands Access and Advances Pipeline of Innovative Therapies
BioCryst*s ORLADEYO Achieves Remarkable Growth, Forecasts Accelerated Path to Profitability
ORLADEYO: A Game-Changer in the Treatment of Hereditary Angioedema
Biocryst Pharmaceuticals Inc Fails to Attain Profitability Despite Revenue Boost during Q2 2023
Compelling quarter by Biocryst Pharmaceuticals Inc all along the fiscal fourth quarter of 2022
The company disclosed the loss has been reduced remarkably, in the July to September 30 2022 period